2019 LMG Life Sciences research has officially begun!
March 22, 2019
Now accepting firm surveys and partner interviews
US
FDA: Medical Device
| FDA: Medical Devices — Highly Recommended |
|---|
| Hogan Lovells |
| Hyman Phelps & McNamara |
| King & Spalding |
| Sidley Austin |
| FDA: Medical Devices — Recommended |
|---|
| Arnold & Porter |
| McDermott Will & Emery |
| Morgan Lewis & Bockius |
| Ropes & Gray |
Healthcare Pricing & Reimbursement
| Healthcare: Pricing & Reimbursement — Highly Recommended |
|---|
| Arnold & Porter |
| Hogan Lovells |
| Sidley Austin |
| Healthcare: Pricing & Reimbursement — Recommended |
|---|
| Epstein Becker Green |
| King & Spalding |
| Latham & Watkins |
| McDermott Will & Emery |
| Morgan Lewis & Bockius |
| Reed Smith |
Patent Strategy & Management
Product Liability
White-Collar/Govt. Investigations
| White-Collar/Government Investigation — Highly recommended |
|---|
| Cleary Gottlieb Steen & Hamilton |
| Cooley |
| Covington & Burling |
| Gibson Dunn & Crutcher |
| Hogan Lovells |
| King & Spalding |
| Morgan Lewis & Bockius |
| Ropes & Gray |
| Sidley Austin |
| WilmerHale |
| White-Collar/Government Investigation — Recommended |
|---|
| Arnold & Porter |
| Latham & Watkins |
| McDermott Will & Emery |
| Nelson Hardiman |
| Schulte Roth & Zabel |
| White & Case |
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Brennan, Jeffrey | Non-IP Litigation & Enforcement | Antitrust | Washington, D.C. |
| Columbia, Sarah | Intellectual Property | General Patent Litigation | |
| Gaede, William | Intellectual Property | General Patent Litigation, Hatch-Waxman Patent Litigation | San Francisco |
| Hogan, Sarah | Financial & Corporate | Licensing & Collaboration | Boston |
| Jacobsen, Raymond | Non-IP Litigation & Enforcement | Antitrust | Washington, D.C. |
| Kalogerou, Byron S | Financial & Corporate | Mergers & Acquisitions | Boston |
| Mohr, Judy | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Menlo Park |
| Peeples-Dyer, Veleka | Regulatory | FDA: Medical Device, FDA: Pharmaceutical | Washington, D.C. |
| Pollard, Vernessa | Regulatory | FDA: Medical Device, FDA: Pharmaceutical | Washington, D.C. |
| Radensky, Paul | Regulatory | FDA: Medical Device, Healthcare Pricing & Reimbursement, FDA: Pharmaceutical | Washington, D.C. |
| Stephens, Reed | Non-IP Litigation & Enforcement | White-Collar/Govt. Investigations | Washington, D.C. |
| Werling, Kristian | Financial & Corporate | Licensing & Collaboration, Mergers & Acquisitions | Chicago |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Non-IP Litigation & Enforcement
McDermott Will & Emery
National player McDermott Will & Emery, and in particular, DC-based Ray Jacobsen, has been retained as lead counsel to defend Impax Laboratories in generic pharmaceuticals pricing antitrust litigation, a multidistrict litigation consolidated in the Eastern District of Pennsylvania. This MDL consolidates over 70 cases alleging that the leading generic pharmaceutical manufacturers conspired to raise the price of 18 different generic drugs. The class-action litigation stems from a number of government investigations by Congress, state attorneys general, and the Department of Justice.
Regulatory
McDermott Will & Emery
McDermott Will & Emery is a full-service law firm with a group dedicated to serving the life sciences industry. The firm offers a regulatory practice that provides expertise in FDA regulation in addition to healthcare pricing and reimbursements. The team is comprised of lawyers with exceptional experience in handling regulatory issues, from product development to post-market regulatory compliance.
Vernessa Pollard assists medical device companies in regulatory compliance and enforcement. She has lately been involved in the emerging industry of digital health, advising clients on the navigation of regulatory pathways in the new area. Pollard's practice also includes solving common regulatory issues, including compliance issues regarding the FDA's Good Manufacturing Practice and Quality System Regulation. Veleka Peeples-Dyer regularly assists biopharmaceutical companies in FDA product approvals and regulatory compliance. She also assists in advising and strategizing with procedures and policies as well.
Handling pricing and reimbursement matters is Paul Radensky, whose practice concentrates on Medicare reimbursements and compliance. "Paul is unique in the field among his peers," a client says. "He has exceptional expertise in the areas of reimbursement, coding, compliance and regulatory matters."
Articles
Now accepting firm surveys and partner interviews